Courtney D Dinardo Selected Research

ruxolitinib

1/2018

A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Courtney D Dinardo Research Topics

Disease

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2021
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 01/2018
3	Neoplasms (Cancer) 01/2023 - 01/2018
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 01/2019
1	Fatigue 01/2023
1	Infections 08/2021
1	Febrile Neutropenia 08/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 11/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Anemia 01/2018

Drug/Important Bio-Agent (IBA)

3	venetoclaxIBA 01/2023 - 08/2021
2	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023
1	pevonedistatIBA 01/2023
1	EnzymesIBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 08/2021
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 08/2021
1	Cladribine FDA LinkGeneric 08/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2021
1	HomoharringtonineIBA 01/2019
1	eltrombopag FDA Link 11/2018
1	ruxolitinibIBA 01/2018

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2018
2	Drug Therapy (Chemotherapy) 10/2021 - 08/2021
1	Immunotherapy 01/2022